CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

NewAmsterdam Pharma Corporation

Nicole Rosenberger, Senior Vice President, Head of Information Technology

Beyond the Contract: The Art of Building Successful MSP Partnerships

Nicole Rosenberger

Nicole Rosenberger

MSP Relationship Champion

Managed services are often viewed as a cost-saving mechanism. In my experience, that's the least interesting reason to use them. The real value of managed service providers (MSPs) is that they allow high-growth companies to build enterprisegrade IT capabilities long before they have the headcount to support them. The art is knowing where they create value and where they should never replace internal leadership.


There is no shortage of guidance on negotiating contracts, measuring SLAs and managing vendor performance. While those disciplines are important, they are only part of the equation. In my experience, the greatest differentiator isn't the contract or SLAs but how well an MSP becomes integrated into your organization. Focus on the partnership and integration practices that, in my experience, have consistently given my organizations an advantage when leveraging MSPs.


I've joined several organizations as their first IT executive, where every new hire competes with critical business investments. In those environments, the right MSP becomes not just a service provider but an accelerator that enables enterprise capabilities long before the organization could build them internally. Finding a partner that can work with you and complement your team is invaluable and allows you to start implementing infrastructure, systems and security that did not exist.


Early in my first Head of IT role, a mentor gave me advice that has shaped every technology organization I've built. He told me to find partners that want to grow with you and have a genuine reason for the relationship to succeed. I still use that advice when selecting MSPs.


My organizations select vendors that are stable but also growing. While large providers have their place, I've found that smaller, growing MSPs often deliver a level of responsiveness that's difficult to match. For an emerging biotech, being one of the vendor’s more important customers often results in stronger partnerships, greater flexibility and more executive attention when challenges arise.


Finding vendors that can truly be a partner to my organization versus an order taker enables us to get opinions from experts that are working with multiple clients, bring broader perspectives to challenges and become as invested in our success as we are. As our company grows and matures, the relationship evolves with us.


“Find partners that want to grow with you and have a genuine reason for the relationship to succeed.”


Once we've identified an operational need, such as a help desk, I assemble a small cross-functional group to participate in the selection process. While it may not be a formal RFP in an emerging company, involving future stakeholders creates ownership, encourages honest feedback and significantly improves adoption once the MSP is onboard.


One of the most overlooked aspects of successful managed services is how the provider is integrated into the organization. We intentionally introduce our MSP personnel as members of the IT organization, not as the vendor. This reinforces that they are an extension of our team while giving the MSP personnel a genuine sense of ownership in our success. We have management meetings to discuss what’s working and what’s not, and where we can help our people or add to our services. It goes beyond the normal company-vendor relationship and my key to having a successful MSP relationship.


Regardless of company size, I believe several responsibilities should always remain internal: IT strategy, cybersecurity governance, executive communication, business relationship management and technology prioritization. MSPs can execute technology exceptionally well, but they shouldn't determine the direction of your business.


MSPs create the greatest value when they own repeatable operational functions such as help desk, endpoint management, infrastructure operations, security operations center (SOC) services, network monitoring and routine administration. These services allow internal teams to focus on business enablement, innovation and strategic initiatives.


The best MSP relationships don't feel like vendor relationships at all. They feel like an extension of your own organization aligned on outcomes, invested in your success and committed to growing alongside you. We spend a great deal of time evaluating technology, negotiating contracts and measuring performance. But the organizations that get the greatest value from managed services are the ones that invest just as much effort in building the partnership as they do in selecting the provider. If communication is limited to ticket queues and quarterly SLA reviews, both sides miss the opportunity to improve the business. Like any successful partnership, trust, transparency and shared accountability matter just as much as technical expertise.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.

Editorial Lens

Technology leaders increasingly depend on external partners whose value is measured not only by delivery, but by trust, accountability and alignment with internal priorities. Rosenberger’s perspective gives IT decision-makers a useful lens for evaluating MSP relationships as long-term operating partnerships rather than simple vendor arrangements.

The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/leadership-perspective/nicole-rosenberger-nwid-3685.html